Stock 1228 CANBRIDGE PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart CANbridge Pharmaceuticals Inc.

Equities

1228

KYG1821D1097

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:27 2024-07-12 am EDT 		5-day change 1st Jan Change
0.37 HKD -1.33% Intraday chart for CANbridge Pharmaceuticals Inc. +15.62% -62.63%
Apr. 23 Canbridge Pharmaceuticals Shelves Glioblastoma Drug After Phase II Clinical Trials MT
Apr. 22 CANbridge Pharmaceuticals Inc. Announces Results of CAN008 Phase II Clinical Trial for the Treatment of Glioblastoma Multiforme CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
CANBRIDGE PHARMACEUTICALS INC.
Specialty & Advanced Pharmaceuticals
-1.33%+15.62%-62.63%-78.74% - 20.41M
Bullish
Bearish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. 1228 Stock
  4. Charts CANbridge Pharmaceuticals Inc.
  5. Comparison Chart